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Skeletal muscle fibers are giant multinucleated cells wherein individual nuclei govern
the protein synthesis in a finite volume of cytoplasm; this is termed the myonuclear
domain (MND). The factors that controlMND size remain to be defined. In the present
study, we studied the contribution of the NAD+-dependent deacetylase, sirtuin 1
(SIRT1), to the regulation of nuclear number and MND size. For this, we isolated
myofibers from mice with tissue-specific inactivation (mKO) or inducible over-
expression (imOX) of SIRT1 and analyzed the 3D organisation of myonuclei. In imOX
mice, the number of nuclei was increased whilst the average MND size was decreased
as compared to littermate controls. Our findings were the opposite in mKO mice.
Muscle stem cell (satellite cell) numbers were reduced in mKO muscles, a possible
explanation for the lower density of myonuclei in these mice; however, no change was
observed in imOX mice, suggesting that other factors might also be involved, such as
the functional regulation of stem cells/muscle precursors. Interestingly, however, the
changes in the MND volume did not impact the force-generating capacity of muscle
fibers. Taken together, our results demonstrate that SIRT1 is a key regulator of MND
sizes, although the underlyingmolecularmechanisms and the cause-effect relationship
between MND and muscle function remain to be fully defined.
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1 | INTRODUCTION
Skeletal muscle fibers are large cells containing hundreds of nuclei,
with each nucleus hypothesised to control the gene transcription and
protein synthesis in a finite volume of cytoplasm, which is termed the
myonuclear domain (MND) (Edgerton & Roy, 1991; Hall & Ralston,
1989; Ralston & Hall, 1992). Regular spacing between nuclei and
optimal MND sizes are required to facilitate transcriptional regulation
(Volk, 2013) and minimise the transport distances of gene products
(Bruusgaard, Liestol, Ekmark, Kollstad, & Gundersen, 2003). The
molecular signaling pathways that determine nuclear positioning and
subsequent MND sizes remain unclear.
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Recently, we have demonstrated that the transcriptional coactiva-
tor, peroxisomeproliferator-activated receptor-γ coactivator 1-α (PGC-
1α), plays a key role in regulating the volume of MNDs in myofibers.
Indeed, despite the absence of noticeable changes when PGC-1α is
specifically inactivated inmuscles, its overexpression induces a dramatic
increase in the number of myonuclei and thus a decrease in the MND
volume (Ross et al., 2016). As PGC-1α is a central regulator of
mitochondrial biogenesis, this alteration is thought to increase
transcriptional capacity for the de novo synthesis of bioenergetic
proteins (Ross et al., 2016). Sirtuin 1 (SIRT1) is a class III NAD+-
dependant deacetylase, which targets and modulates the activity of
various proteins, and in particular is a pivotal mediator of PGC-1α
activity (Gerhart-Hines et al., 2007; Gurd, Yoshida, Lally, Holloway, &
Bonen, 2009); thus we aimed to determine whether directly modifying
SIRT1 activity would impact nuclear number/positioning and MND
sizes. For this, we used mice with either a skeletal muscle-specific
inactivation (mKO) or inducible overexpression (imOX) of SIRT1.
We found that overexpression of SIRT1 resulted in increased
myonuclear density and thus reducedMND sizes; conversely, ablation of
SIRT1 resulted in reduced myonuclear density and thus increased MND
sizes. These results mirror those for PGC-1α, which is activated
downstream of SIRT1. Altered satellite cell numbers might explain the
modulation of myonuclear density within muscle fibers, although
differences were only observed in mKO mice, suggesting that other
factors such as stemcell fate/regulationmight alsobe involved, andSIRT1
is known to regulate proliferation of muscle precursor cells (Rathbone,
Booth, & Lees, 2009). These results implicate SIRT1 in MND size
regulation, although the precise mechanisms remain to be determined.
2 | MATERIALS AND METHODS
2.1 | Animals
SIRT1 muscle-specific overexpressing mice (imOX) and SIRT1 muscle-
specific knockout mice (mKO) were generated as previously described
(Philp et al., 2011; Schenk et al., 2011; Svensson, LaBarge, Martins, &
Schenk, 2017). The transgene in mKO mice was driven by the muscle-
specific muscle creatine kinase (MCK) promoter, while the transgene in
imOX mice was driven by the human α-skeletal actin promoter in a
tamoxifen (TMX)-inducible manner (∼50-fold increase in SIRT1 protein
level). For simplicity, wild-type (WT) mice refer to littermate controls
possessing the LoxP-flanked SIRT1 transgenes, but with no muscle-
specific Cre. Three imOX, five mKO, and eightWTmice were euthanised
at 4months of age, whichwas 4weeks after TMXadministration in imOX
mice; all littermate controls for imOX mice also received TMX. All
experiments were approved and conducted in accordance with the
Animal Care Program at UCSD.
2.2 | Solutions
Relaxing and activating solutions contained 4mMMg-ATP, 1mM free
Mg2+, 20mM imidazole, 7 mM EGTA, 14.5 mM creatine phosphate,
and KCl to adjust the ionic strength to 180mM and pH to 7.0. The
concentrations of free Ca2+ were 10−9.00M (relaxing solution) and
10−4.50M (activating solution).
2.3 | Myofiber permeabilization
After dissection, the tibialis anterior (TA) muscle was treated with
skinning solution (relaxing solution containing glycerol; 50:50 v/v) for
24 hr at 4 °C, after which they were transferred to −20 °C (Frontera &
Larsson, 1997).
2.4 | Myonuclear organization of single myofibers
On the day of experiment (within 4 weeks of muscle dissection), single
myofibers were randomly isolated. Arrays of approximately nine
myofibers were prepared at room temperature (RT). For each
myofiber, both ends were clamped to half-split copper meshes
designed for electron microscopy (SPI G100 2010C-XA, width,
3mm), which had been glued to cover slips (Menzel–Gläser,
22 × 50mm, thickness 0.13–0.16mm). For the measurement of
nuclear coordinates, fibers were mounted at a fixed sarcomere length
of ≈2.20 μm. This was a prerequisite for exact determination of nuclei
spatial organisation as it allowed accurate comparisons between
myofibers (Ross et al., 2016).
Arrays were subsequently fixed in 4% PFA/PBS, and further
permeabilized with 0.1% Triton-X100/PBS for 10min each. fibers
were then subjected to actin staining (Rhodamine-conjugated
Phalloidin, Molecular Probes, Eugene, OR, R415, 1:100 in PBS) and
nuclear staining (DAPI, Molecular Probes, D3571, 1:1000 in PBS).
Images were acquired using a confocal microscope (Zeiss Axiovert
200, Cambridge, UK, objective ×20) equipped with CARV II confocal
imager (BD Bioscience, San Jose, CA). To visualize muscle fibers in 3D,
stacks of 100 images were acquired (1 μm z increments) and analyzed
with a custom-made Matlab programme. A distribution score (“g”) is a
measure of the regularity of spacing between nuclei; this was
calculated as described before (Bruusgaard et al., 2003). Briefly, a
theoretical optimum distribution (MO) and a theoretical random
distribution (MR) were generated for each fiber, based on the numbers
and coordinates of the corresponding myonuclei. This was compared
with the experimental distribution (ME), and a “g” score was calculated
with the equation: g = (ME−MR)/(MO−MR).
2.5 | Single muscle fiber force production
Single muscle fibers were dissected following the same procedure as
above. They were then individually attached between connectors
leading to a force transducer (model 400A; Aurora Scientific, Aurora,
ON) and a lever arm system (model 308B; Aurora Scientific).
Sarcomere length was set to ≈2.50 μm (known to be optimal for force
measurement) and the temperature to 15 °C (Lindqvist, Cheng,
Renaud, Hardeman, & Ochala, 2013; Ochala, Iwamoto, Ravenscroft,
Laing, & Nowak, 2013; Ochala, Ravenscroft, Laing, & Nowak, 2012).
Fiber cross-sectional area (CSA) was estimated under a brightfield
microscope using the fiber width and depth, and assuming an elliptical
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circumference (Lindqvist et al., 2013; Ochala et al., 2012, 2013). The
absolute maximal isometric force generation was calculated as the
difference between the total tension in the activating solution (pCa
4.50) and the resting tension measured in the same fiber while in the
relaxing solution. Specific force was defined as absolute force divided
by CSA.
2.6 | Immunohistochemistry of muscle cryosections
Ten µm thick cryosections of TA muscle were cut in transverse
orientation, air-dried on slides and stored at −80 °C. On the day of
staining, slides were thawed, dried for 10min and rehydrated in PBS
for 10min.
For satellite cell staining: sections were then fixed in 4% PFA/PBS,
and permeabilised with 0.5% Triton-X100/PBS for 10min each. After
washing in PBS, sections were incubated for 1 hr in mouse-on-mouse
block/PBS (Vector Laboratories, Peterborough, UK, MKB-2213),
followed by blocking for 1 hr in 10% goat serum/PBS. Antibodies to
Pax7 (mouse IgG1 isoform, Developmental Studies Hybridoma Bank,
supernatant) and laminin (rabbit IgG, Dako, Z0097) were applied
overnight in 10% goat serum/PBS at dilutions of 1:10 and 1:500
respectively (temperature 4 °C). After washes, species and isotype
specific secondaryantibodiesconjugated toAlexa488or594 (Molecular
Probes) were applied for 1 hr in 10% goat serum/PBS, with the addition
of DAPI (all at a dilution of 1:1000). After washing, slides were mounted
in Fluoromount (Southern Biotech, Birmingham, AL).
For fiber type/myosin isoform staining: after rehydration as above,
sections were blocked in 1% bovine serum albumin/PBS for 10min.
Antibodies directed against different myosin isoforms were then
applied in blocking buffer at dilutions of 1:50, overnight at room
temperature: mouse anti-myosin slow/type I (IgG2b isoform, clone
BA-F8); mouse anti-myosin fast/type IIa (IgG1 isoform, clone SC-71);
mouse anti-myosin fast/type IIx (IgM isoform, clone 6H1); mouse anti-
myosin fast/type IIb (IgM isoform, clone BF-F3). In addition, an
antibody recognizing all fast/type II isoforms was utilized (mouse IgG1
isoform, clone MY-32, Sigma–Aldrich, St. Louis, MO, dilution 1:200).
Sections were then washed in PBS/0.025% Tween-20, and incubated
with isotype specific secondary antibodies conjugated to Alexa 488 or
594 in blocking buffer (dilution 1:500) for 1 hr. After washing in PBS,
slides were mounted in Fluoromount. BA-F8, SC-71, and BF-F3 were
gifts fromDr. Stefano Schiaffino (University of Padua, Italy). 6H1was a
gift from Dr. Joseph Hoh (University of Sydney, Australia).
2.7 | Statistical analysis
For all the parameters, no significant differences were observed
between WT mice corresponding to the mKO or imOX groups, so all
WT animals were pooled for data analysis. Additionally, within each
group (WT, mKO, or imOX), no differences were found between
animals, so all the individual data were pooled together. Data are
presented as mean ± standard error of the mean (SEM). One-way
ANOVA with Tukey post-correction was used to test for significance
(p < 0.05).
3 | RESULTS
We isolated individual muscle fibers from imOX (n = 27), mKO (n = 55),
and WT mice (n = 103). We then membrane-permeabilised the
myofibers, generated confocal microscope reconstructions, and evalu-
ated the 3D spatial arrangement of myonuclei (Figure 1) (Ross et al.,
2016). Fiber CSA was similar between WT and imOX, but significantly
larger inmKOmice compared to theother groups.Weobserved that the
number of nuclei per mm fiber length was significantly smaller in mKO
than WT, and larger in imOX than WT (Figure 2a).
As shown previously (Ross et al., 2016), the number of nuclei per
mm fiber length and the average MND size for a particular fiber was
related to its CSAwith a positive, linear correlation; this was the case in
all groups (Figures 2c and 2d; in panel C, R2 values for WT, mKO, and
imOX were 0.20, 0.34, and 0.50 respectively; in panel D, R2 values
were 0.59, 0.64, and 0.58 respectively). Additionally, there was a
significant difference between elevations of the regression lines of
both mKO and imOX compared toWT mice, indicating that: (1) across
all fiber sizes, there were more nuclei per mm fiber length in imOX and
fewer in mKO compared to WT rodents; and that (2), in accordance
with this, MND sizes were larger in mKO and smaller in imOX
compared toWT rodents (Figures 2c and 2d). MND sizes are positively
correlated with average nearest neighbour (NN) distances between
nuclei, and therefore these values were significantly greater in mKO
than WT, and significantly smaller in imOX than WT (Figure 2b).
The MND measurements provide valuable information on the
average volume controlled by each myonucleus; however, they do not
allow characterisation of the spatial arrangement of myonuclei within
the whole fiber. Therefore, to evaluate the regularity of nuclear
positioning within myofibers, a distribution score (“g”) was evaluated
(Bruusgaard et al., 2003), but did not differ significantly among the
groups (Figure 3a), implying that, overall, a similar, regular spacing is
maintained between nuclei in all groups.
Nuclear number and function are prerequisites for preserving the
intrinsic contractile characteristics (e.g., force per unit of CSA, termed
specific force) ofmuscle fibers (Omairi et al., 2016). Thus, wemeasured
the specific force of membrane-permeabilised muscle fibers from
imOX (n = 12), mKO (n = 12) and WT mice (n = 12 fibers from 3
animals/genotype). We did not observe any significant differences
among the groups (Figure 3b). To evaluate whether there were any
differences in force production across the range of fiber sizes, we
plotted absolute force against fiber CSA, and again observed no
difference in linear regression lines (Figure 3c).
Since the addition of myonuclei to myofibers during development
and hypertrophy is known to be dependent on muscle stem cells,
termed satellite cells, we assessed their numbers in cryosections of
skeletal muscle (Figure 4a-c). We found that the abundance of satellite
cells was reduced in mKO (p = 0.011), but unchanged in imOX muscles
(p = 0.11) compared to WT mice (Figure 4d). The regulation of
myonuclear number is also known to be dependent on fiber type, with
slow/type I fibers displaying smaller myonuclear domains. However,
we observed no differences in the relative proportions of type I, IIa, IIx,
and IIb fibers among the groups (Figure 5).
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4 | DISCUSSION
In the present study, our aim was to characterise the contribution of
SIRT1 to nuclear positioning and/or MND sizes in skeletal muscle
fibers. We performed a series of experiments using mice where SIRT1
is inactivated (mKO) or overexpressed (imOX) specifically in skeletal
muscle. Strikingly, we observed that the myonuclear number was
significantly increased in imOX mice resulting in a decrease in the
FIGURE 1 Typical muscle fibers from WT, mKO, and imOX mice. Single muscle fibers were isolated from the tibialis anterior of age-
matched mKO (SIRT1 muscle-specific knockout), imOX (SIRT1 muscle-specific overexpression), and WT (wild-type) mice. These were then
stained for actin (Rhodamine Phalloidin; red) and myonuclei (DAPI, blue). Scale bar: 50 μm. Fiber cross-sectional areas are shown in the graph
(each data point represents one fiber; line and error bars are mean ± SEM)
FIGURE 2 Myonuclear number and domain sizes. MND =myonuclear domain, CSA = fiber cross-sectional area, NN = nearest neighbour. (a)
number of nuclei per mm of fiber length; (b) Nearest neighbour distances between each myonucleus; (c) scatter plot/correlation of nuclei per
mm length of fiber and CSA; (d) scatter plot/correlation of MND volume and CSA. Each data point represents one fiber; line and error bars
are mean ± SEM. Asterisks directly above data columns denote significance versus WT; Asterisks with a line/bracket denote significance
between two other groups. All regression lines demonstrated a statistically significant correlation (p < 0.05). In addition, linear regression
analysis showed that the elevations between each data line were significantly different from each other (p < 0.01 in each case; brackets and
asterisks denote differences between lines)
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average MND size, whilst in mKO mice, nuclear number was
decreased, resulting in increased MND size (Figures 1 and 2).
It is well known that slow-twitch type I fibers have smaller
myonuclear domains than fast-twitch type II fibers, presumably to
FIGURE 3 Myonuclear positioning and intrinsic force production
in myofibers. (a) Order score calculated from nearest neighbour
distances between myonuclei of each fiber (a higher order score
indicates more even/regular spacing between nuclei). (b) Specific
force production (i.e., absolute force normalised to fiber cross
sectional area, CSA). (c) Scatter plot/correlation between CSA and
absolute force. Each data point represents one fiber; line and error
bars are mean ± SEM
FIGURE 4 Satellite cell numbers in skeletal muscle cryosections.
(a–c) Satellite cells were identified as Pax7+ nuclei residing
underneath the basal lamina (green, Pax7; blue, DAPI; red, laminin).
(d) Satellite cell numbers per mm2 of cryosection (tibialis anterior
muscle). Each data point represents one animal (8 fields of view at
×20 magnification per animal). Scale bar: 20 μm
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support the larger number of mitochondria in the former. Our results
and those obtained previously suggest that the SIRT1-dependent
modulation of MND size is not dependent on fiber type or effects on
mitochondrial biogenesis. This is supported by the following findings:
(1) the mKO and imOX models have no alterations in the relative
proportions of type I, IIa, IIx, and IIb fibers in TA muscles (Figure 5 and
Svensson et al., 2017); and (2) both mKO and imOX models have no
alterations in the expression of a large panel of mitochondrial markers,
including those required for biogenesis (Philp et al., 2011; Svensson
et al., 2017). Thus, we suggest that the effects of SIRT1 on MND size
are not secondary to a shift in fiber type or oxidative capacity.
Our previous results in mice with conditional knockout or
overexpression of PGC-1α in skeletal muscle mirror the current
findings related to SIRT1; increasing the levels of PGC-1α resulted in
smaller MND sizes, and ablation resulted in larger MND sizes (Ross
et al., 2016). PGC-1α is activated by SIRT1, which suggests a hierarchy
of signaling elements in the determination of myonuclear number.
Intriguingly, the SIRT1 imOX or mKO model do not show any
alterations in PGC-1α protein level or activation, suggesting that other
proteins (for instance GCN5) are able to activate PGC-1α in the
absence of SIRT1 (Philp et al., 2011; Svensson et al., 2017). Given the
complexity of the SIRT1 signaling network, this suggests that SIRT1 is
able to modulate MND sizes through mechanisms that are not
dependent on PGC-1α, and that multiple factors may be involved.
How might SIRT1 activity and MND size be related? Nuclear
addition in myofibers depends on a process that starts with the
activation of satellite cells, the muscle resident stem cells, which then
become muscle progenitors termed myoblasts. These cells then
proliferate, and fuse with myofibers, resulting in the addition of new
nuclei. Several lines of evidence support the fact that SIRT1 stimulates
myoblast proliferation (Rathbone et al., 2009). Down-regulating or
inactivating SIRT1 in the muscles of mice deregulates the myogenic
programme, delays the activation of satellite cells and impairs muscle
growth and repair (Ryall et al., 2015; Tang & Rando, 2014). Our results
demonstrate that satellite cell numbers are reduced in mKO mice
compared with WT, a factor which might result in reduced
incorporation of nuclei into muscle fibers and thus the increased
MND sizes (Figures 2 and 4). However, no alterations in satellite cell
numbers were observed in imOX mice, making other factors (such as
the SIRT1-dependent regulation of the myogenic programme) a likely
mechanism.
The prevailing theory in the literature is thatmaintainingMND size
is a prerequisite for preserving the intrinsic force-generating capacity
of muscle fibers (Qaisar et al., 2012). Indeed, in the myostatin null
mouse, which displays hypertrophy where MND sizes are increased,
perhaps resulting in nuclei being forced to extend their influence
beyond their maximum capacity or physiological “ceiling.” Contractile
protein density and force production are then compromised. In
contrast, mice overexpressing insulin-like growth factor 1 (IGF1) in
muscle display hypertrophywith preservedMND sizes, and contractile
protein density and specific force production are normal (Qaisar et al.,
2012). Importantly, while the MND size increased and decreased in
mKO and imOXmice, respectively, the intrinsic ability of muscle fibers
to produce force was not affected. We interpret these data to suggest
that the MND needs to be more extensively changed (as compared to
control/healthy muscle) in order to have a detrimental impact on
muscle function, and that the alterations in MND observed in this
study were within a range that was appropriate for normal contractile
function. It should be noted that force measurements were obtained
from chemically skinned fibers, a methodology that assesses function
purely at the contractile level, and excludes factors relating to, for
example, calcium handling or ATP production. Therefore, one cannot
rule out an effect of altered MND size on function in intact muscle. As
such, it will be very interesting in further work to precisely define the
point at which such change in MND negatively affects muscle
functional properties.
In conclusion, our data demonstrate that SIRT1 contributes to the
control of nuclear density and MND size in muscle fibers, and that
there appears to be a physiological “zone,” or range of MND sizes
FIGURE 5 Fiber type composition in skeletal muscle cryosections.
Antibodies against myosin isoforms: (a) fast/type IIa (green) and fast/
type IIb (red); (b) fast type IIx (green). In addition, an antibody against
type I myosin confirmed a complete absence of slow fibers (data not
shown). (c) counts of each fiber type, with median and range of 3
animals per genotype. 400 + fibers counted per animal across several
low magnification images. Scale bar: 50 μm
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which are compatible with normal contractile function. Considering
that increasing SIRT1 activity decreased the MND volume (i.e.,
increased the number of nuclei), it will be of interest in future studies to
investigate SIRT1 as a therapeutic target, for diseases where nuclear
alteration is part of the pathophysiology, such as in muscular
dystrophies.
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